Mcpherson'S Limited
MCP.ASXConsumer Staples
McPherson's is a leading supplier of health and beauty consumer products in Australasia, with operations in Australia, New Zealand and Asia.
Market Data
$0.130
-0.0%$18.7M
-100000.0x
$-0.127
0.00%
-0.4%
Latest Earnings
1H26 Financial Results
25 February 2026
McPherson's reported 1H26 revenue from continuing operations of $66.0M, down 6.7% due to transition challenges under its new operating model. Despite lower revenue, Underlying EBITDA grew 10.6% to $2.2M driven by reduced fixed costs, though the company posted a statutory net loss of $2.3M including material items. Management expects moderate year-on-year growth in underlying FY26 EBITDA, majority weighted to 2H26 as the operating model stabilizes. Key points: Underlying EBITDA grew 10.6% to $2.2M despite revenue decline, supported by reduced fixed costs under new operating model; Strong operating cash flow of $5.9M and improved net cash position to $12.6M from $8.8M; Core brand Manicare grew 6.7% and Swisspers grew 11.7% showing brand strength
Recent Announcements
Trading Update
McPherson's Limited (ASX: MCP) has withdrawn its previous guidance of moderate year-on-year EBITDA growth for FY26, citing lower-than-expected sales as the new operating model stabilizes, supplier cost surcharges from macroeconomic pressures, and supply chain challenges; however, the company maintains a strong net cash position and will continue its share buy-back program.
Ceasing to be a substantial holder
Microequities Asset Management Pty Limited has ceased to be a substantial holder in McPherson's Limited (MCP), as notified via Form 605 lodged with the ASX on March 26, 2026.
1H26 Financial Results Presentation
McPherson's Limited (ASX:MCP) announced its 1H26 financial results showing revenue of $66.0 million (down 6.7% from 1H25) and underlying EBITDA of $2.2 million (up 10.6%), reflecting a period of stabilization under the company's new operating model that transitioned to a 3PL distribution model and exited its Kingsgrove warehouse. The company announced an up to $2.0 million on-market share buyback and provided guidance for moderate year-on-year underlying FY26 EBITDA growth weighted toward 2H26.
1H26 Financial Results
McPherson's reported 1H26 revenue from continuing operations of $66.0M, down 6.7% due to transition challenges under its new operating model. Despite lower revenue, Underlying EBITDA grew 10.6% to $2.2M driven by reduced fixed costs, though the company posted a statutory net loss of $2.3M including material items. Management expects moderate year-on-year growth in underlying FY26 EBITDA, majority weighted to 2H26 as the operating model stabilizes. Key points: Underlying EBITDA grew 10.6% to $2.2M despite revenue decline, supported by reduced fixed costs under new operating model; Strong operating cash flow of $5.9M and improved net cash position to $12.6M from $8.8M; Core brand Manicare grew 6.7% and Swisspers grew 11.7% showing brand strength
1H26 Appendix 4D and Financial Report
McPherson's reported 1H26 revenue of $66.0M (down 6.7% from continuing operations) but underlying EBITDA improved 10.6% to $2.2M despite the revenue decline, driven by operational model benefits. The company recorded a net loss of $2.3M, impacted by a $1.9M non-cash impairment of the Fusion Health brand and transition-related challenges affecting Dr LeWinn's and Fusion Health brands. Key points: Underlying EBITDA improved 10.6% to $2.2M despite revenue decline, demonstrating operational efficiency gains; Strong performance from core brands Manicare (up 6.7%) and Swisspers (up 11.7%); Core brands now represent 93.9% of sales, up from 88.4% in prior period
Get real-time alerts for MCP
Receive AI-powered earnings summaries and instant notifications when Mcpherson'S Limited releases results.
Register Free